Free Eye Drops Distribution To Mitigate Drug Side Effects Cleared By HHS OIG
Executive Summary
Program relies on a third-party vendor managing a Risk Evaluation and Mitigation Strategy associated with the drug to facilitate delivery of eye drops to patients.